Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives

References

• Mannino DM, Homa DM, Akinbami L, et al. Surveillance for asthma – United States, 1980–1999. MMWR Morb Mortal Wkly Rep 2002;51:1–13
   Google Scholar
• American Lung Association epidemiology and statistics unit research and program services. Trends in asthma morbidity and mortality. May, 2005
   Google Scholar
• Lethbridge-Çejku M, Schiller JS, Bernadel L. Summary health statistics for U.S. Adults: National health interview survey, 2002. National Center for Health Statistics. Vital Health Stat 10 2004;222: 1–151
   Google Scholar
• Dey AN, Schiller JS, Tai DA. Summary health statistics for U.S. children: National health interview survey, 2002. National Center for Health Statistics. Vital Health Stat 10 2004; 221:1–78
   Google Scholar
• DeFrances C, Hall M. 2002 National hospital discharge survey. Adv Data 2004;342:1–29
   Google Scholar
• Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985–1994. J Allergy Clin Immunol 2000;106: 494–9
   Google Scholar
• McCraig L, Burt C. National hospital ambulatory medical care survey: 2002 emergency department summary. Adv Data 2004;340:1–34
   PubMedGoogle Scholar
• Smith DH, Malone DC, Lawson KA, et al. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997;156:787–93
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Morbidity and mortality: 2002 chart book on cardiovascular, lung, and blood diseases. Bethesda, MD: National Institutes of Health, 2002
   Google Scholar
• Osman LM, Calder C, Robertson R, et al. Symptoms, quality of life, and health service contact among young adults with mild asthma. Am J Respir Crit Care Med 2000;161:498–503
   PubMed Web of Science ®Google Scholar
• Rosenzweig JR, Edwards L, Lincourt W, et al. The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. Respir Med 2004;98:1157–65
   PubMed Web of Science ®Google Scholar
• Smith N, Ley P, Seale J, et al. Health beliefs, satisfactions, and compliance. Patient Educ Couns 1987;10:279–86
   PubMed Web of Science ®Google Scholar
• Hazell M, Frank T, Frank P. Health related quality of life in individuals with asthma related symptoms. Respir Med 2003;97:1211–8
   Google Scholar
• Magid DJ, Houry D, Ellis J, et al. Health-related quality of life predicts emergency department utilization for patients with asthma. Ann Emerg Med 2004;43:551–7
   PubMed Web of Science ®Google Scholar
• Siu AL, Reuben DB, Ouslander JG, et al. Using multidimensional health measures in older persons to identify risk of hospitalization and skilled nursing placement. Qua Life Res 1993;2:253–61
   PubMed Web of Science ®Google Scholar
• Osman IM, Godden DJ, Friend JA, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52:67–71
   PubMed Web of Science ®Google Scholar
• Hartert TV, Speroff T, Togias A, et al. Risk factors for recurrent asthma hospital visits and death among a population of indigent older adults with asthma. Ann Allergy Asthma Immunol 2002;89:467–73
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the diagnosis and management of asthma – update on selected topics 2002. NIH publication 02–5075. Bethesda, Md: National Heart, Lung, and Blood Institute, June 2002
   Google Scholar
• National Institutes of Health. Global initiative for asthma: global strategy for asthma management and prevention NHLBI/ WHO workshop report. Publication No. 95–3659. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 1995
   Google Scholar
• Shapiro G, Lumry W, Wolfe J, et al. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma. Am J Respir Cril Care Med 2000;161:527–34
   PubMed Web of Science ®Google Scholar
• Kavuru M, Melamed J, Gross G, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000;105:1108–16
   PubMed Web of Science ®Google Scholar
• Aubier M, Pieters WR, Schlosser NJ, et al. Salmeterol/fluticasone propionate (50/500 μg) in combination in the Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999;93:876–84
   PubMed Web of Science ®Google Scholar
• Nelson HS, Busse WW, Kerwin E, et al. Advair: Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 2000;106:1088–95
   PubMed Web of Science ®Google Scholar
• Ringdal N, Eliraz A, Pruzinec R, et al.; International Study Group. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 2003;97:234–41
   Google Scholar
• Calhoun WJ, Nelson HS, Nathan RA, et al. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting β2-agonists alone. Am J Respir Crit Care Med 2001;164:759–63
   PubMed Web of Science ®Google Scholar
• Legorreta AP, Leung KM, Berkbigler D, et al. Outcomes of a population-based asthma management program: quality of life, absenteeism, and utilization. Annals Allergy Asthma Immunol 2000;85:28–34
   PubMed Web of Science ®Google Scholar
• Osborne ML, Vollmer WM, Pedula KL, et al. Lack of correlation of symptoms with specialist-assessed long-term asthma severity. Chest 1999;115:85–91
   PubMed Web of Science ®Google Scholar
• Calhoun WJ, Sutton LB, Emmett A, et al. Asthma variability in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol 2003;112:1088–94
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83
   PubMedGoogle Scholar
• Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902–7
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76–83
   PubMed Web of Science ®Google Scholar
• Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the asthma quality of life questionnaire. Chest 1999;115:1265–70
   PubMed Web of Science ®Google Scholar
• Juniper E, Guyatt G, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:87–7
   Google Scholar
• Duan N, Manning W, Morris C, et al. A comparison of alternative models for the demand of medical care. J Business Econ Stat 1983;1:115–26
   Google Scholar
• Efron B, Tibshirani R. An introduction to the bootstrap. Boca Raton: Chapman & Hall/CRC, 1993
   Google Scholar
• Afifi A, Clark V, May S. Special regression topics. In: Computer-aided multivariate analysis. 4th edn. Boca Raton: Chapman & Hall/CRC, 2004
   Google Scholar
• Pearlman DS, White MV, Lieberman AK, et al. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Ann Allergy Asthma Immunol 2002;88:227–35
   PubMed Web of Science ®Google Scholar
• Warschburger P, Busch S, Bauer CP, et al. Health-related quality of life in children and adolescents with asthma: results from the ESTAR study. J Asthma 2004;41:463–70
   PubMed Web of Science ®Google Scholar
• Sprenkle MD, Niewoehner DE, Nelson DB, et al. The veterans short form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD. Chest 2004; 126:81–9
   PubMed Web of Science ®Google Scholar
• Buhl R, Kardos P, Richter K, et al. The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing. Curr Med Res Opin 2004;20:1209–20
   PubMed Web of Science ®Google Scholar
• Markson LE, Vollmer WM, Fitterman L, et al. Insight into patient dissatisfaction with asthma treatment. Arch Intern Med 2001;161:379–84
   PubMed Web of Science ®Google Scholar
• Malonne H, Lachman A, Van den Brande P. Impact of montelukast on symptoms in mild-to-moderate persistent asthma and exercise-induced asthma: results of the ASTHMA survey. Curr Med Res Opin 2002;18:512–519
   Google Scholar
• Mahajan P, Okamoto L. Patient satisfaction with the Diskhaler® and the Diskus® inhaler, a new multidose powder delivery system for the treatment of asthma. Clin Ther 1997;19: 1126–33
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004; 2:1–12
   PubMedGoogle Scholar
• O’Connor RD, O’Donnell JC, Pinto LA, et al. Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma. Chest 1999;121:1028–35
   Google Scholar
• Stempel DA, O’Donnell JC, Meyer JW. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol 2002;109:433–9
   PubMed Web of Science ®Google Scholar
• Schulman, Ronca, Bucuvalas Inc. (SRBI). Asthma in America: a landmark survey. New York: SRBI, 1998
   Google Scholar